Breast cancer patients with brain metastasis undergoing GKRS.

Maysa M Abu-KhalafSivraj MuralikrishnanChristos HatzisDeepti CanchiJames B YuVeronica Chiang

Published in: Breast cancer (Tokyo, Japan) (2018)

GKRS is a promising therapy for treating brain metastasis from BC, particularly in those with HER-2 positivity and high-performance scores even in those patients with > 5 brain metastases. Furthermore, GKRS may also be a useful adjunct to surgical resection in such patients. High rates of neurological death remain from BC brain metastases; however, and need further investigation.

Keyphrases

brain metastases
small cell lung cancer
end stage renal disease
newly diagnosed
ejection fraction
chronic kidney disease
cerebral ischemia
multiple sclerosis
patient reported outcomes
brain injury